
### [MONDO:0017159](http://purl.obolibrary.org/obo/MONDO_0017159)
**Label:** syndrome with pulmonary hypertension as a major feature

**Subclasses:** [MONDO:0012032](http://purl.obolibrary.org/obo/MONDO_0012032) (Braddock syndrome), [MONDO:0013458](http://purl.obolibrary.org/obo/MONDO_0013458) (hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome), 

**Mapped go classes:** [GO:0006412](http://purl.obolibrary.org/obo/GO_0006412) (translation), [GO:0006434](http://purl.obolibrary.org/obo/GO_0006434) (seryl-tRNA aminoacylation), [GO:0097056](http://purl.obolibrary.org/obo/GO_0097056) (selenocysteinyl-tRNA(Sec) biosynthetic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006418](http://purl.obolibrary.org/obo/GO_0006418) (tRNA aminoacylation for protein translation), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004812](http://purl.obolibrary.org/obo/GO_0004812) (aminoacyl-tRNA ligase activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0004828](http://purl.obolibrary.org/obo/GO_0004828) (serine-tRNA ligase activity), [GO:0070158](http://purl.obolibrary.org/obo/GO_0070158) (mitochondrial seryl-tRNA aminoacylation), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), 

**Class expressions from DL-Learner:**

- [GO:0097056](http://purl.obolibrary.org/obo/GO_0097056) (selenocysteinyl-tRNA(Sec) biosynthetic process) 60.00%
- [GO:0070158](http://purl.obolibrary.org/obo/GO_0070158) (mitochondrial seryl-tRNA aminoacylation) 60.00%
- [GO:0006434](http://purl.obolibrary.org/obo/GO_0006434) (seryl-tRNA aminoacylation) 60.00%
- [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix) 60.00%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 60.00%
- [GO:0004828](http://purl.obolibrary.org/obo/GO_0004828) (serine-tRNA ligase activity) 60.00%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%


